Cost-effectiveness analysis of trifluridine/tipiracil in the treatment of heavily pretreated metastatic gastric cancer from the perspective of Chinese healthcare system
The Chinese population registered in the Chinese Clinical Trial Registry (ChiCTR2400080940) and clinical trial (NCT05029102).
Authors
- Jiahui Dai (ORCID: https://orcid.org/0000-0002-6874-7114)
- Ran Xia (ORCID: https://orcid.org/0000-0002-5165-7956)
- Ying Ting (ORCID: https://orcid.org/0009-0007-9716-3146)
- Yadong Wang (ORCID: https://orcid.org/0000-0001-6500-6217)
- Xuefeng Xie (ORCID: https://orcid.org/0000-0003-1913-9590)
- Yuanyuan Zhang (ORCID: https://orcid.org/0000-0001-7426-1092)
Institutions
- Anhui Medical University (CN)
Publication Details
- Journal
- BMJ Open
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1136/bmjopen-2023-080846
- Citations
- 1
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.42